BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18208851)

  • 1. COST-ENLIGHT strategic workshop on hadron (particle) therapy, CERN, Geneva, 3-4 May 2007.
    Taylor RE
    Br J Radiol; 2008 Mar; 81(963):169-71. PubMed ID: 18208851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ENLIGHT: European network for Light ion hadron therapy.
    Dosanjh M; Amaldi U; Mayer R; Poetter R;
    Radiother Oncol; 2018 Jul; 128(1):76-82. PubMed ID: 29625810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ENLIGHT: The European Network for Light Ion Hadron Therapy.
    Dosanjh M; Cirilli M; Greco V; Meijer AE
    Health Phys; 2012 Nov; 103(5):674-80. PubMed ID: 23032898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ENLIGHT and other EU-funded projects in hadron therapy.
    Dosanjh M; Jones B; Mayer R
    Br J Radiol; 2010 Oct; 83(994):811-3. PubMed ID: 20846982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ENLIGHT and LEIR biomedical facility.
    Dosanjh M; Cirilli M; Navin S
    Phys Med; 2014 Jul; 30(5):544-50. PubMed ID: 24695274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Union of light ion therapy centers in Europe (ULICE EC FP7) - Objectives and achievements of joint research activities.
    Pötter R; Balosso J; Baumann M; Bert C; Davies J; Enghardt W; Fossati P; Harris S; Jones B; Krämer M; Mayer R; Mock U; Pullia M; Schreiner T; Dosanjh M; Debus J; Orecchia R; Georg D;
    Radiother Oncol; 2018 Jul; 128(1):83-100. PubMed ID: 30001932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle therapy at the Heidelberg Ion Therapy Center (HIT) - Integrated research-driven university-hospital-based radiation oncology service in Heidelberg, Germany.
    Combs SE; Jäkel O; Haberer T; Debus J
    Radiother Oncol; 2010 Apr; 95(1):41-4. PubMed ID: 20227124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basics of particle therapy II biologic and dosimetric aspects of clinical hadron therapy.
    Rong Y; Welsh J
    Am J Clin Oncol; 2010 Dec; 33(6):646-9. PubMed ID: 20395789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of optimized single and multifield irradiation plans of antiproton, proton and carbon ion beams.
    Bassler N; Kantemiris I; Karaiskos P; Engelke J; Holzscheiter MH; Petersen JB
    Radiother Oncol; 2010 Apr; 95(1):87-93. PubMed ID: 20304512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dreams, themes and particle beams--an oncologist's perspective on technology trickle-down from the LHC.
    Jena R
    Br J Radiol; 2014 Apr; 87(1036):20130828. PubMed ID: 24593272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer.
    Lodge M; Pijls-Johannesma M; Stirk L; Munro AJ; De Ruysscher D; Jefferson T
    Radiother Oncol; 2007 May; 83(2):110-22. PubMed ID: 17502116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiobiology with heavy charged particles: a historical review.
    Skarsgard LD
    Phys Med; 1998 Jul; 14 Suppl 1():1-19. PubMed ID: 11542635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model for the relative biological effectiveness of protons: the tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes.
    Wedenberg M; Lind BK; Hårdemark B
    Acta Oncol; 2013 Apr; 52(3):580-8. PubMed ID: 22909391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late effects from hadron therapy.
    Blakely EA; Chang PY
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S134-40. PubMed ID: 15971329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calculations related to the possible use of photons, neutrons, negatively charged pions, protons, and alpha particles in radiotherapy.
    Alsmiller RG; Santoro RT; Armstrong TW; Barish J; Chandler KC; Chapman GT
    Radiat Res; 1974 Dec; 60(3):369-87. PubMed ID: 10881718
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiproton radiotherapy.
    Bassler N; Alsner J; Beyer G; DeMarco JJ; Doser M; Hajdukovic D; Hartley O; Iwamoto KS; Jäkel O; Knudsen HV; Kovacevic S; Møller SP; Overgaard J; Petersen JB; Solberg TD; Sørensen BS; Vranjes S; Wouters BG; Holzscheiter MH
    Radiother Oncol; 2008 Jan; 86(1):14-9. PubMed ID: 18158194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of physical dose distributions with hadron beams: comparing photon IMRT with IMPT.
    Oelfke U; Bortfeld T
    Technol Cancer Res Treat; 2003 Oct; 2(5):401-12. PubMed ID: 14529305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of carbon ions versus protons.
    Weber U; Kraft G
    Cancer J; 2009; 15(4):325-32. PubMed ID: 19672150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons.
    Peeters A; Grutters JP; Pijls-Johannesma M; Reimoser S; De Ruysscher D; Severens JL; Joore MA; Lambin P
    Radiother Oncol; 2010 Apr; 95(1):45-53. PubMed ID: 20106540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.